Revolutionizing cancer treatments and outcomes by driving access to genomic profiling, clinical trials, and compassionate use
Revolutionizing cancer treatments and outcomes by driving access to genomic profiling, clinical trials, and compassionate use
FIRASAH is on a mission to drive unprecedented access to precision cancer treatment across Saudi Arabia and MENA by building pathways to advanced genomic profiling, innovative clinical trials, and compassionate use of cutting-edge oncology therapies that will create hope for patients in need and catalyze the formation of a thriving life sciences ecosystem across the region.
By connecting patients' genomic data to best-fit targeted trials and treatments, FIRASAH is developing a proprietary program and core technology platform that will transform the experience of patients living with cancer, driving longer and higher-quality lifespan and outcomes
Moving at breakneck speed and catalyzing its deep network of healthcare leaders, FIRASAH has already secured vital support and engagement with key KSA stakeholders and leading global delivery partners to push scientific and clinical frontiers, and revolutionize patient outcomes
In addition to the immediate and positive impact FIRASAH is determined to make on patients' lives, FIRASAH is anticipating a range of broader economic impacts for KSA and the region alike, supporting rapid innovation from biopharma companies, yielding substantial governmental cost savings, and spurring new long-term job creation
